bi 1265162
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 23, 2017 (NCT03349723)
Timeline
Indications
Mechanism of action
SCNN1A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04267276 | Phase 1 | Feb 18, 2020 | Boehringer Ingelheim |
| NCT04059094 | Phase 2 | Sep 2, 2019 | Boehringer Ingelheim |
| NCT03907280 | Phase 1 | Apr 23, 2019 | Boehringer Ingelheim |
| NCT03576144 | Phase 1 | Jul 11, 2018 | Boehringer Ingelheim |
| NCT03349723 | Phase 1 | Nov 23, 2017 | Boehringer Ingelheim |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 5 | 5 | 2 | 2017 |
1 organizations
Page 1 / 1